Charles Mowbray
@charlesmowbray.bsky.social
Drug discovery and development for neglected patients suffering from infectious diseases including leishmaniasis, Chagas disease and viral infections @DNDi in Geneva
Posts on LinkedIn at https://www.linkedin.com/in/charlesmowbray/
Posts on LinkedIn at https://www.linkedin.com/in/charlesmowbray/
Reposted by Charles Mowbray
Beni survived #SleepingSickness thanks to timely diagnosis & innovative oral treatments.
This #WorldChildrensDay we call for support to develop urgently needed life-saving treatments for children like Beni living with NTDs.
Watch his story in our new film www.youtube.com/watch?v=GcIx...
This #WorldChildrensDay we call for support to develop urgently needed life-saving treatments for children like Beni living with NTDs.
Watch his story in our new film www.youtube.com/watch?v=GcIx...
Beni: Surviving Sleeping Sickness
YouTube video by Drugs for Neglected Diseases initiative (DNDi)
www.youtube.com
November 20, 2025 at 9:56 AM
Beni survived #SleepingSickness thanks to timely diagnosis & innovative oral treatments.
This #WorldChildrensDay we call for support to develop urgently needed life-saving treatments for children like Beni living with NTDs.
Watch his story in our new film www.youtube.com/watch?v=GcIx...
This #WorldChildrensDay we call for support to develop urgently needed life-saving treatments for children like Beni living with NTDs.
Watch his story in our new film www.youtube.com/watch?v=GcIx...
Reposted by Charles Mowbray
JUST RELEASED: Open science in a closed world 🌍📘Our new policy report shows how open, collaborative science and pro-access IP approaches can accelerate medical innovation & equitable access to health tools for all. #MakeScienceOpen youtube.com/shorts/UmBAr...
Open Science in a Closed World
YouTube video by Drugs for Neglected Diseases initiative (DNDi)
youtube.com
November 17, 2025 at 11:05 AM
JUST RELEASED: Open science in a closed world 🌍📘Our new policy report shows how open, collaborative science and pro-access IP approaches can accelerate medical innovation & equitable access to health tools for all. #MakeScienceOpen youtube.com/shorts/UmBAr...
Reposted by Charles Mowbray
Are you going to #ECTMIH2025 in Hamburg next week?
Our team will be speaking about epidemic and pandemic-prone viruses, neglected tropical diseases #NTDs & female genital #schistosomiasis.
👉Find out more: dndi.org/events/2025/...
#beatNTDs
Our team will be speaking about epidemic and pandemic-prone viruses, neglected tropical diseases #NTDs & female genital #schistosomiasis.
👉Find out more: dndi.org/events/2025/...
#beatNTDs
September 25, 2025 at 3:10 PM
Are you going to #ECTMIH2025 in Hamburg next week?
Our team will be speaking about epidemic and pandemic-prone viruses, neglected tropical diseases #NTDs & female genital #schistosomiasis.
👉Find out more: dndi.org/events/2025/...
#beatNTDs
Our team will be speaking about epidemic and pandemic-prone viruses, neglected tropical diseases #NTDs & female genital #schistosomiasis.
👉Find out more: dndi.org/events/2025/...
#beatNTDs
I am incredibly impressed and proud of the work of our team and many collaborators in bringing forward this exciting new preclinical candidate as a contribution to building pandemic preparedness. Congratulations to everyone who has contributed to and supported this program!
Great news! 🎉
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
September 24, 2025 at 12:27 PM
I am incredibly impressed and proud of the work of our team and many collaborators in bringing forward this exciting new preclinical candidate as a contribution to building pandemic preparedness. Congratulations to everyone who has contributed to and supported this program!
Reposted by Charles Mowbray
Great news! 🎉
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
September 24, 2025 at 8:40 AM
Great news! 🎉
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
Following an independent expert review, we have formally nominated the broad-spectrum pan-coronavirus antiviral ASAP-0017445 as a pre-clinical drug candidate.
🔗Read the press release here: dndi.org/press-releas...
Reposted by Charles Mowbray
🎉 Our annual report is out! In 2024, we advanced work on 🔬 32 projects, including 16 clinical trials in 7 disease areas, conducted across 🌍 60 sites in 23 countries.
Browse our report to learn how solidarity in science is benefiting the most neglected 👉 bit.ly/4eRbJfq
Browse our report to learn how solidarity in science is benefiting the most neglected 👉 bit.ly/4eRbJfq
DNDi 2024 Annual Report
Browse our interactive Annual Report to learn how solidarity in science is benefiting the most neglected.
bit.ly
July 15, 2025 at 3:33 PM
🎉 Our annual report is out! In 2024, we advanced work on 🔬 32 projects, including 16 clinical trials in 7 disease areas, conducted across 🌍 60 sites in 23 countries.
Browse our report to learn how solidarity in science is benefiting the most neglected 👉 bit.ly/4eRbJfq
Browse our report to learn how solidarity in science is benefiting the most neglected 👉 bit.ly/4eRbJfq
Reposted by Charles Mowbray
The @ec.europa.eu’s new Medical Countermeasures Strategy could be a critical tool to support end-to-end R&D specifically as it will support pandemic-prone diseases such as Ebola or dengue. [1/4] 👇
@charlesmowbray.bsky.social @rachaelcrockett.bsky.social @childsmichelle.bsky.social
@charlesmowbray.bsky.social @rachaelcrockett.bsky.social @childsmichelle.bsky.social
July 10, 2025 at 2:40 PM
The @ec.europa.eu’s new Medical Countermeasures Strategy could be a critical tool to support end-to-end R&D specifically as it will support pandemic-prone diseases such as Ebola or dengue. [1/4] 👇
@charlesmowbray.bsky.social @rachaelcrockett.bsky.social @childsmichelle.bsky.social
@charlesmowbray.bsky.social @rachaelcrockett.bsky.social @childsmichelle.bsky.social
Exciting and important opportunity for early-career researchers to apply for michelsonprizes.smapply.org for disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
The Michelson Prizes: Next Generation Grants
michelsonprizes.smapply.org
May 9, 2025 at 7:19 AM
Exciting and important opportunity for early-career researchers to apply for michelsonprizes.smapply.org for disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
Reposted by Charles Mowbray
⏰ Only 10 days to go! Apply now to become our next #PatientRepresentative.
We’re looking for someone who can help ensure our programmes and commitments truly reflect the needs of the communities we serve.
📆 4 May 2025
👉 bit.ly/4jvtTVE
📣 Help us spread the word!
We’re looking for someone who can help ensure our programmes and commitments truly reflect the needs of the communities we serve.
📆 4 May 2025
👉 bit.ly/4jvtTVE
📣 Help us spread the word!
April 24, 2025 at 12:59 PM
⏰ Only 10 days to go! Apply now to become our next #PatientRepresentative.
We’re looking for someone who can help ensure our programmes and commitments truly reflect the needs of the communities we serve.
📆 4 May 2025
👉 bit.ly/4jvtTVE
📣 Help us spread the word!
We’re looking for someone who can help ensure our programmes and commitments truly reflect the needs of the communities we serve.
📆 4 May 2025
👉 bit.ly/4jvtTVE
📣 Help us spread the word!
Reposted by Charles Mowbray
We're looking for a new #PatientRepresentative to join our Board and help align our programmes and commitments with the needs of the communities we serve.
🗓️ Apply by 4 May 2025
🔗 Details: bit.ly/dndi-patient...
#PatientCentricity #PatientAdvocacy #GlobalHealth #JoinUs
@drluispizarro.bsky.social
🗓️ Apply by 4 May 2025
🔗 Details: bit.ly/dndi-patient...
#PatientCentricity #PatientAdvocacy #GlobalHealth #JoinUs
@drluispizarro.bsky.social
April 8, 2025 at 9:24 AM
We're looking for a new #PatientRepresentative to join our Board and help align our programmes and commitments with the needs of the communities we serve.
🗓️ Apply by 4 May 2025
🔗 Details: bit.ly/dndi-patient...
#PatientCentricity #PatientAdvocacy #GlobalHealth #JoinUs
@drluispizarro.bsky.social
🗓️ Apply by 4 May 2025
🔗 Details: bit.ly/dndi-patient...
#PatientCentricity #PatientAdvocacy #GlobalHealth #JoinUs
@drluispizarro.bsky.social
Reposted by Charles Mowbray
Did you know that we can manage patents in a way that serves the public good?
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
How patents can serve the common good
YouTube video by Drugs for Neglected Diseases initiative (DNDi)
youtube.com
April 10, 2025 at 9:53 AM
Did you know that we can manage patents in a way that serves the public good?
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
Reposted by Charles Mowbray
'We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us do that.'
Read our full opinion piece co-authored by Ed Griffen (@griffen-ed.bsky.social) and Pascale Boulet ⤵️
cen.acs.org/pharmaceutic...
Read our full opinion piece co-authored by Ed Griffen (@griffen-ed.bsky.social) and Pascale Boulet ⤵️
cen.acs.org/pharmaceutic...
Opinion: How patents can serve the common good
We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us do that
cen.acs.org
April 4, 2025 at 7:38 AM
'We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us do that.'
Read our full opinion piece co-authored by Ed Griffen (@griffen-ed.bsky.social) and Pascale Boulet ⤵️
cen.acs.org/pharmaceutic...
Read our full opinion piece co-authored by Ed Griffen (@griffen-ed.bsky.social) and Pascale Boulet ⤵️
cen.acs.org/pharmaceutic...
Interested in how drugs are discovered? My colleague Fanny Beltran Escudié is explaining more in the latest episode of our Drug Discovery Explained series. Over to you Fanny Beltran Escudié... youtu.be/qAg0osQQqVQ @dndi.org
youtu.be
March 26, 2025 at 4:31 PM
Interested in how drugs are discovered? My colleague Fanny Beltran Escudié is explaining more in the latest episode of our Drug Discovery Explained series. Over to you Fanny Beltran Escudié... youtu.be/qAg0osQQqVQ @dndi.org
Reposted by Charles Mowbray
Reposted by Charles Mowbray
Climate-sensitive infectious diseases are rising, hitting those with the least access to testing and treatment the hardest. We need science-driven solutions to #EndTheNeglect and ensure no one is left behind. 🌍
🔗 dndi.org/advocacy/con...
#WorldNTDDay #BeatNTDs
🔗 dndi.org/advocacy/con...
#WorldNTDDay #BeatNTDs
January 29, 2025 at 9:27 AM
Climate-sensitive infectious diseases are rising, hitting those with the least access to testing and treatment the hardest. We need science-driven solutions to #EndTheNeglect and ensure no one is left behind. 🌍
🔗 dndi.org/advocacy/con...
#WorldNTDDay #BeatNTDs
🔗 dndi.org/advocacy/con...
#WorldNTDDay #BeatNTDs
Reposted by Charles Mowbray
Today, we spotlight #FGS, an #NTD caused by a parasitic worm 🪱
In Dec, we decided to start conducting research for this disease, recognizing the urgent need for better treatment.
🔗For more info, see the full carousel here: www.instagram.com/p/DFaaKpzoRs...
#WorldNTDDay #BeatNTDs #EndTheNeglect
In Dec, we decided to start conducting research for this disease, recognizing the urgent need for better treatment.
🔗For more info, see the full carousel here: www.instagram.com/p/DFaaKpzoRs...
#WorldNTDDay #BeatNTDs #EndTheNeglect
January 29, 2025 at 2:36 PM
Today, we spotlight #FGS, an #NTD caused by a parasitic worm 🪱
In Dec, we decided to start conducting research for this disease, recognizing the urgent need for better treatment.
🔗For more info, see the full carousel here: www.instagram.com/p/DFaaKpzoRs...
#WorldNTDDay #BeatNTDs #EndTheNeglect
In Dec, we decided to start conducting research for this disease, recognizing the urgent need for better treatment.
🔗For more info, see the full carousel here: www.instagram.com/p/DFaaKpzoRs...
#WorldNTDDay #BeatNTDs #EndTheNeglect
An inspiring meeting with the LCI in Hamburg this week provides the perfect lead-in to World NTD Day tomorrow!
#WorldNTDDay #EndTheNeglect #beatNTD
@dndi.org
#WorldNTDDay #EndTheNeglect #beatNTD
@dndi.org
January 29, 2025 at 6:18 PM
An inspiring meeting with the LCI in Hamburg this week provides the perfect lead-in to World NTD Day tomorrow!
#WorldNTDDay #EndTheNeglect #beatNTD
@dndi.org
#WorldNTDDay #EndTheNeglect #beatNTD
@dndi.org
Innovation is key to eliminating neglected tropical diseases (NTDs). This #WorldNTDDay, we’re
joining @DNDi to invest in solutions that bring treatments, diagnostics, and hope to affected
communities. #EndTheNeglect #beatNTDs
joining @DNDi to invest in solutions that bring treatments, diagnostics, and hope to affected
communities. #EndTheNeglect #beatNTDs
January 29, 2025 at 6:01 PM
Innovation is key to eliminating neglected tropical diseases (NTDs). This #WorldNTDDay, we’re
joining @DNDi to invest in solutions that bring treatments, diagnostics, and hope to affected
communities. #EndTheNeglect #beatNTDs
joining @DNDi to invest in solutions that bring treatments, diagnostics, and hope to affected
communities. #EndTheNeglect #beatNTDs
Leishmaniasis is one of the diseases where @dndi.org and our partners are exploring the role of Host Directed Therapies. We aim to compliment direct acting antiparasitic and antiviral drugs in tackling complex neglected infectious diseases which affect >1bn people.
www.linkedin.com/posts/charle...
www.linkedin.com/posts/charle...
Charles Mowbray on LinkedIn: Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous…
It was a pleasure to work with Andrea Lafleur, Stephane Daffis and Byron Arana on this article published last year in Vaccines MDPI. Leishmaniasis is one of…
www.linkedin.com
January 24, 2025 at 11:11 AM
Leishmaniasis is one of the diseases where @dndi.org and our partners are exploring the role of Host Directed Therapies. We aim to compliment direct acting antiparasitic and antiviral drugs in tackling complex neglected infectious diseases which affect >1bn people.
www.linkedin.com/posts/charle...
www.linkedin.com/posts/charle...
www3.nhk.or.jp/nhkworld/en/...
Very happy to raise awareness of the needs of >1bn people affected by terrible neglected diseases such as #Dengue and to highlight the exciting work we have been doing with our colleagues at #BenevolentAI.
Dengue item is at minutes 9:00-12:30 in AI story from 7:30
Very happy to raise awareness of the needs of >1bn people affected by terrible neglected diseases such as #Dengue and to highlight the exciting work we have been doing with our colleagues at #BenevolentAI.
Dengue item is at minutes 9:00-12:30 in AI story from 7:30
Riding High on New Wave of Renewable Energy Tech - BIZ STREAM | NHK WORLD-JAPAN
[On-Site Report: Riding High on New Wave of Renewable Energy Tech] This episode focuses on advances in renewable energy and features a massive lightweight hard sail designed for cargo ships and an ult...
www3.nhk.or.jp
January 20, 2025 at 10:19 AM
www3.nhk.or.jp/nhkworld/en/...
Very happy to raise awareness of the needs of >1bn people affected by terrible neglected diseases such as #Dengue and to highlight the exciting work we have been doing with our colleagues at #BenevolentAI.
Dengue item is at minutes 9:00-12:30 in AI story from 7:30
Very happy to raise awareness of the needs of >1bn people affected by terrible neglected diseases such as #Dengue and to highlight the exciting work we have been doing with our colleagues at #BenevolentAI.
Dengue item is at minutes 9:00-12:30 in AI story from 7:30